SLC45A3 and prostate carcinoma: Only a few reports describe a putative functional impact of read-throughs on cancer [4,8] with the most convincing one reported for SLC45A3-ELK4 in prostate cancer, where the read-through promotes cell proliferation but wild-type ELK4 does not [4].